336 related articles for article (PubMed ID: 12488350)
1. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
Abbey SE; Potter LR
Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
Potter LR
Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B).
Abbey-Hosch SE; Cody AN; Potter LR
Hypertension; 2004 May; 43(5):1103-9. PubMed ID: 15037564
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
5. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations.
Abbey SE; Potter LR
J Biol Chem; 2002 Nov; 277(45):42423-30. PubMed ID: 12196532
[TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
8. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue: a possible mechanism of heterologous desensitization.
Potter LR; Hunter T
J Biol Chem; 2000 Oct; 275(40):31099-106. PubMed ID: 10915802
[TBL] [Abstract][Full Text] [Related]
9. Homologous and lysophosphatidic acid-induced desensitization of the atrial natriuretic peptide receptor, guanylyl cyclase-A, in MA-10 leydig cells.
Müller D; Cortes-Dericks L; Budnik LT; Brunswig-Spickenheier B; Pancratius M; Speth RC; Mukhopadhyay AK; Middendorff R
Endocrinology; 2006 Jun; 147(6):2974-85. PubMed ID: 16527839
[TBL] [Abstract][Full Text] [Related]
10. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
11. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
14. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
Thibault G; Grove KL; Deschepper CF
Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
[TBL] [Abstract][Full Text] [Related]
15. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization.
Simon A; Harrington EO; Liu GX; Koren G; Choudhary G
Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L248-56. PubMed ID: 19036874
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
19. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
20. Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B.
Hirsch JR; Skutta N; Schlatter E
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F370-4. PubMed ID: 12709393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
